Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes

Neurology. 1989 Jan;39(1):44-7. doi: 10.1212/wnl.39.1.44.

Abstract

The plasma of patients with inherited defects in peroxisomal biogenesis (ie, Zellweger's syndrome, infantile Refsum's disease, and neonatal adrenoleukodystrophy) shows evidence of a disturbance in the metabolism of saturated and monoenoic fatty acids with carbon chain lengths greater than 22 (VLCFA). Zellweger's syndrome plasma alone contains, in addition, increased amounts of a number of n-6 polyenoic VLCFA including 24:5, 26:5, 28:5, 30:5, and 30:6 fatty acids. These fatty acids facilitate the biochemical discrimination of Zellweger's syndrome from other related phenotypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenoleukodystrophy / blood*
  • Adrenoleukodystrophy / diagnosis
  • Adrenoleukodystrophy / genetics
  • Child, Preschool
  • Diagnosis, Differential
  • Diffuse Cerebral Sclerosis of Schilder / blood*
  • Fatty Acids / blood*
  • Genetic Linkage
  • Humans
  • Infant
  • Infant, Newborn
  • Microbodies / ultrastructure
  • Phenotype
  • Refsum Disease / blood*
  • Refsum Disease / diagnosis
  • X Chromosome
  • Zellweger Syndrome / blood*
  • Zellweger Syndrome / diagnosis

Substances

  • Fatty Acids